ABSTRACT
Photovoltaic (PV) panels have a crucial role in coping with the global warming mitigation and the energetic crisis currently affecting the European Community. However, from the circular perspective of end-of-life (EoL) management, there are still big issues to be solved in order to recover materials from this kind of e-wastes. Because of several reasons (e.g. type of embedded materials, illegal shipments, location of manufacturers) EoL businesses do not have the interest in approaching them. This poses a significant environmental concern in terms of their management. This work wants to assess the profitability of a specific PV module recycling plant, by evaluating several market contexts in which multiple scenarios of material price, investment and process costs will be considered. The results for a 3000 tonnes plant show that profitability is not verified in the absence of an avoided landfill cost. Instead, when a value of 200 /tonnes is applied, the net present value is positive in 35.2% of the scenarios and at 87.6% when a value of 350 /tonnes is considered. The policy choice of this value requires linking the PV module disposal fee to the circular benefits associated with its recovery.
Subject(s)
Electronic Waste , Waste Management , Waste Management/methods , Waste Disposal Facilities , RecyclingABSTRACT
Before entering human clinical studies to evaluate their safety and effectiveness, new drugs and novel medical treatments are subject to extensive animal testing that are expensive and time-consuming. By contrast, advanced technologies enable the development of animal-free models that allow the efficacy of innovative therapies to be studied without sacrificing animals, while providing helpful information and details. We report on the powerful combination of 3D bioprinting (3DB) and photo-thermal therapy (PTT) applications. To this end, we realize a 3DB construct consisting of glioblastoma U87-MG cells in a 3D geometry, incorporating biomimetic keratin-coated gold nanoparticles (Ker-AuNPs) as a photo-thermal agent. The resulting plasmonic 3DB structures exhibit a homogeneous cell distribution throughout the entire volume while promoting the localization of Ker-AuNPs within the cells. A 3D immunofluorescence assay and transmission electron microscopy (TEM) confirm the uniform distribution of fluorescent-labeled Ker-AuNPs in the volume and their capability to enter the cells. Laser-assisted (λ = 532 nm) PTT experiments demonstrate the extraordinary ability of Ker-AuNPs to generate heating, producing the highest temperature rise of about 16 °C in less than 2 min.
Subject(s)
Glioblastoma , Hyperthermia, Induced , Metal Nanoparticles , Photothermal Therapy , Biomimetic Materials , Glioblastoma/therapy , Gold/chemistry , Humans , Keratins/chemistry , Metal Nanoparticles/chemistry , Photothermal Therapy/methodsABSTRACT
Gliomas are the most common primary malignant brain tumors. Glioblastoma, IDH-wildtype (GBM, CNS WHO grade 4) is the most aggressive form of glioma and is characterized by extensive hypoxic areas that strongly correlate with tumor malignancy. Hypoxia promotes several processes, including stemness, migration, invasion, angiogenesis, and radio- and chemoresistance, that have direct impacts on treatment failure. Thus, there is still an increasing need to identify novel targets to limit GBM relapse. Polysialic acid (PSA) is a carbohydrate composed of a linear polymer of α2,8-linked sialic acids, primarily attached to the Neural Cell Adhesion Molecule (NCAM). It is considered an oncodevelopmental antigen that is re-expressed in various tumors. High levels of PSA-NCAM are associated with high-grade and poorly differentiated tumors. Here, we investigated the effect of PSA inhibition in GBM cells under low oxygen concentrations. Our main results highlight the way in which hypoxia stimulates polysialylation in U87-MG cells and in a GBM primary culture. By lowering PSA levels with the sialic acid analog, F-NANA, we also inhibited GBM cell migration and interfered with their differentiation influenced by the hypoxic microenvironment. Our findings suggest that PSA may represent a possible molecular target for the development of alternative pharmacological strategies to manage a devastating tumor like GBM.
Subject(s)
Glioblastoma , Neuroblastoma , Glioblastoma/metabolism , Humans , Hypoxia/metabolism , Neoplasm Recurrence, Local , Neural Cell Adhesion Molecules/genetics , Neural Cell Adhesion Molecules/metabolism , Neuroblastoma/metabolism , Sialic Acids/metabolism , Tumor MicroenvironmentABSTRACT
PURPOSE: Degenerative disc disease (DDD) is a common condition causing low-back pain, disability and, eventually, neurological symptoms. This investigation aimed to investigate intervertebral disc DDD-related changes, evaluating histomorphology and cytokines secretion, and their clinical-radiological correlations. METHODS: This is a monocentric prospective observational study. A cohort of patients who underwent microdiscectomy for DDD, from June 2018 to January 2019, were enrolled. Discs samples were examined for histomorphology, chondrons count, immunohistochemistry for Hif-1α, Nf200 and Egr-1. Demographical and clinical data were also collected. RESULTS: Twenty patients were finally included. MRI evaluation showed a Modic I alteration in nine patients and a Modic II in 11. The disability grade was low-moderate (ODI score was ≤ 40%) in eight patients and high (ODI score > 40%) in 12. The Modic I was associated with a low-moderate disability in two (22%) patients and to a high disability in seven (88%) (p < 0.01). In Modic I group and in ODI > 40% groups, there were a significative higher mean disability grade 48.4 (± 8.3)%, number of chondrons per section, cells per chondron, Nf200+ nerve fibers and Hif-1α expression, compared with Modic II and ODI ≤ 40% groups, respectively. There were no differences in terms of Egr-1 expression. CONCLUSIONS: The discs with Modic I MRI signal could represent potential targets for medical treatments, whereas Modic II seems to be a more likely point of no return in a degenerative process. Therefore, further investigations are to better investigate inflammatory pathways and degenerative mechanisms in DDD.
Subject(s)
Intervertebral Disc Degeneration , Intervertebral Disc Displacement , Intervertebral Disc , Diskectomy , Humans , Intervertebral Disc Degeneration/diagnostic imaging , Intervertebral Disc Degeneration/surgery , Lumbar Vertebrae/diagnostic imaging , Lumbar Vertebrae/surgery , Magnetic Resonance Imaging , Prospective StudiesABSTRACT
Psoriasis is a chronic inflammatory systemic disease caused by deregulation of the interleukin-23/-17 axis that allows the activation of Th17 lymphocytes and the reprogramming of keratinocytes proliferative response, thereby inducing the secretion of cyto-/chemokines and antimicrobial peptides. Beside cell-to-cell contacts and release of cytokines, hormones and second messengers, cells communicate each other through the release of extracellular vesicles containing DNA, RNA, microRNAs and proteins. It has been reported the alteration of extracellular vesicles trafficking in several diseases, but there is scarce evidence of the involvement of extracellular vesicles trafficking in the pathogenesis of psoriasis. The main goal of the study was to characterize the release, the cargo content and the capacity to transfer bioactive molecules of extracellular vesicles produced by keratinocytes following recombinant IL-17A treatment if compared to untreated keratinocytes. A combined approach of standard ultracentrifugation, RNA isolation and real-time RT-PCR techniques was used to characterize extracellular vesicles cargo. Flow cytometry was used to quantitatively and qualitatively analyse extracellular vesicles and to evaluate cell-to-cell extracellular vesicles transfer. We report that the treatment of human keratinocytes with IL-17A significantly modifies the extracellular vesicles cargo and release. Vesicles from IL-17A-treated cells display a specific pattern of mRNA which is undid by IL-17A neutralization. Extracellular vesicles are taken up by acceptor cells irrespective of their content but only those derived from IL-17A-treated cells enable recipient cells to express psoriasis-associated mRNA. The results imply a role of extracellular vesicles in amplifying the pro-inflammatory cascade induced in keratinocyte by pro-psoriatic cytokines.
Subject(s)
Extracellular Vesicles/drug effects , Interleukin-17/pharmacology , Keratinocytes/drug effects , Antibodies, Monoclonal, Humanized/pharmacology , Cell Line, Transformed , Chemokine CCL20/biosynthesis , Chemokine CCL20/genetics , Chemokines, CXC/biosynthesis , Chemokines, CXC/genetics , Endocytosis , Extracellular Vesicles/metabolism , Fluoresceins/metabolism , Fluorescent Dyes/metabolism , Gene Expression Profiling , Gene Expression Regulation/drug effects , Humans , Interleukin-6/biosynthesis , Interleukin-6/genetics , Keratinocytes/metabolism , Particle Size , Psoriasis/metabolism , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Recombinant Proteins/pharmacology , Succinimides/metabolism , beta-Defensins/biosynthesis , beta-Defensins/geneticsABSTRACT
Glioblastoma (GBM) cells express large-conductance, calcium-activated potassium (BK) channels, whose activity is important for several critical aspects of the tumor, such as migration/invasion and cell death. GBMs are also characterized by a heavy hypoxic microenvironment that exacerbates tumor aggressiveness. Since hypoxia modulates the activity of BK channels in many tissues, we hypothesized that a hypoxia-induced modulation of these channels may contribute to the hypoxia-induced GBM aggressiveness. In U87-MG cells, hypoxia induced a functional upregulation of BK channel activity, without interfering with their plasma membrane expression. Wound healing and transwell migration assays showed that hypoxia increased the migratory ability of U87-MG cells, an effect that could be prevented by BK channel inhibition. Toxicological experiments showed that hypoxia was able to induce chemoresistance to cisplatin in U87-MG cells and that the inhibition of BK channels prevented the hypoxia-induced chemoresistance. Clonogenic assays showed that BK channels are also used to increase the clonogenic ability of U87-MG GBM cells in presence, but not in absence, of cisplatin. BK channels were also found to be essential for the hypoxia-induced de-differentiation of GBM cells. Finally, using immunohistochemical analysis, we highlighted the presence of BK channels in hypoxic areas of human GBM tissues, suggesting that our findings may have physiopathological relevance in vivo. In conclusion, our data show that BK channels promote several aspects of the aggressive potential of GBM cells induced by hypoxia, such as migration and chemoresistance to cisplatin, suggesting it as a potential therapeutic target in the treatment of GBM.
Subject(s)
Brain Neoplasms/drug therapy , Cell Movement/drug effects , Cisplatin/pharmacology , Drug Resistance, Neoplasm/drug effects , Glioblastoma/drug therapy , Hypoxia/pathology , Large-Conductance Calcium-Activated Potassium Channels/antagonists & inhibitors , Brain Neoplasms/metabolism , Brain Neoplasms/pathology , Cell Death/drug effects , Cell Differentiation/drug effects , Cell Line, Tumor , Cell Membrane/drug effects , Cell Membrane/metabolism , Glioblastoma/metabolism , Glioblastoma/pathology , Humans , Hypoxia/metabolism , Membrane Potentials/drug effects , Tumor Microenvironment/drug effects , Up-Regulation/drug effectsABSTRACT
The present work aimed to synthesise promising antioxidant compounds as a valuable alternative to the currently expensive and easily degradable molecules that are employed as stabilizers in industrial preparation. Taking into account our experience concerning domino Friedel-Crafts/lactonization reactions, we successfully improved and extended the previously reported methodology toward the synthesis of 3,3-disubstituted-3H-benzofuran-2-one derivatives 9-20 starting from polyphenols 1-6 as substrates and either diethylketomalonate (7) or 3,3,3-trifluoromethyl pyruvate (8) as electrophilic counterpart. The antioxidant capacity of the most stable compounds (9-11 and 15-20) was evaluated by both DPPH assay and Cyclic Voltammetry analyses performed in alcoholic media (methanol) as well as in aprotic solvent (acetonitrile). By comparing the recorded experimental data, a remarkable activity can be attributed to few of the tested lactones.
Subject(s)
Antioxidants/pharmacology , Benzofurans/chemical synthesis , Benzofurans/pharmacology , Biphenyl Compounds/chemistry , Electrochemistry/methods , Picrates/chemistry , Acetonitriles/chemistry , Alkylation , Antioxidants/chemistry , Kinetics , Methanol/chemistry , Oxidation-Reduction , Phenols/chemistry , Phenols/pharmacology , Regression Analysis , SolventsABSTRACT
Glioblastomas (GBMs) are brain tumors characterized by diffuse invasion of cancer cells into the healthy brain parenchyma, and establishment of secondary foci. GBM cells abundantly express large-conductance, calcium-activated potassium (BK) channels that are thought to promote cell invasion. Recent evidence suggests that the GBM high invasive potential mainly originates from a pool of stem-like cells, but the expression and function of BK channels in this cell subpopulation have not been studied. We investigated the expression of BK channels in GBM stem-like cells using electrophysiological and immunochemical techniques, and assessed their involvement in the migratory process of this important cell subpopulation. In U87-MG cells, BK channel expression and function were markedly upregulated by growth conditions that enriched the culture in GBM stem-like cells (U87-NS). Cytofluorimetric analysis further confirmed the appearance of a cell subpopulation that co-expressed high levels of BK channels and CD133, as well as other stem cell markers. A similar association was also found in cells derived from freshly resected GBM biopsies. Finally, transwell migration tests showed that U87-NS cells migration was much more sensitive to BK channel block than U87-MG cells. Our data show that BK channels are highly expressed in GBM stem-like cells, and participate to their high migratory activity. J. Cell. Physiol. 232: 2478-2488, 2017. © 2016 Wiley Periodicals, Inc.
Subject(s)
Brain Neoplasms/metabolism , Glioblastoma/metabolism , Large-Conductance Calcium-Activated Potassium Channels/metabolism , Neoplastic Stem Cells/metabolism , AC133 Antigen/metabolism , Biomarkers, Tumor/metabolism , Brain Neoplasms/genetics , Brain Neoplasms/pathology , Cell Line, Tumor , Cell Movement/drug effects , Gene Expression Regulation, Neoplastic , Glioblastoma/genetics , Glioblastoma/pathology , Humans , Large-Conductance Calcium-Activated Potassium Channel alpha Subunits/metabolism , Large-Conductance Calcium-Activated Potassium Channels/antagonists & inhibitors , Large-Conductance Calcium-Activated Potassium Channels/genetics , Membrane Potentials , Neoplasm Invasiveness , Neoplastic Stem Cells/drug effects , Neoplastic Stem Cells/pathology , Phenotype , Potassium Channel Blockers/pharmacology , Primary Cell Culture , Signal Transduction , Spheroids, Cellular , Time Factors , Tumor Cells, Cultured , Up-RegulationABSTRACT
The wasp family Vespidae comprises more than 5000 described species which represent life history strategies ranging from solitary and presocial to eusocial and socially parasitic. The phylogenetic relationships of the major vespid wasp lineages (i.e., subfamilies and tribes) have been investigated repeatedly by analyzing behavioral and morphological traits as well as nucleotide sequences of few selected genes with largely incongruent results. Here we reconstruct their phylogenetic relationships using a phylogenomic approach. We sequenced the transcriptomes of 24 vespid wasp and eight outgroup species and exploited the transcript sequences for design of probes for enriching 913 single-copy protein-coding genes to complement the transcriptome data with nucleotide sequence data from additional 25 ethanol-preserved vespid species. Results from phylogenetic analyses of the combined sequence data revealed the eusocial subfamily Stenogastrinae to be the sister group of all remaining Vespidae, while the subfamily Eumeninae turned out to be paraphyletic. Of the three currently recognized eumenine tribes, Odynerini is paraphyletic with respect to Eumenini, and Zethini is paraphyletic with respect to Polistinae and Vespinae. Our results are in conflict with the current tribal subdivision of Eumeninae and thus, we suggest granting subfamily rank to the two major clades of "Zethini": Raphiglossinae and Zethinae. Overall, our findings corroborate the hypothesis of two independent origins of eusociality in vespid wasps and suggest a single origin of using masticated and salivated plant material for building nests by Raphiglossinae, Zethinae, Polistinae, and Vespinae. The inferred phylogenetic relationships and the open access vespid wasp target DNA enrichment probes will provide a valuable tool for future comparative studies on species of the family Vespidae, including their genomes, life styles, evolution of sociality, and co-evolution with other organisms.
Subject(s)
DNA/genetics , Phylogeny , Transcriptome/genetics , Wasps/classification , Wasps/genetics , Animals , Base Sequence , Open Reading Frames/genetics , RNA, Messenger/genetics , RNA, Messenger/metabolism , Sequence Analysis, RNAABSTRACT
End-of-life vehicles, together with waste from electric and electronic equipment, are known as an important source of secondary raw materials. For many years, their recovery has allowed the restoring of great amounts of metals for new cars production. This article provides a comprehensive mini-review on the end-of-life vehicles recycling topic between 2000 and 2014, with a particular focus on automotive electronics recycling. In fact, in the last years, experts focused their attention on a better exploitation of automotive shredder residue fraction, but not sufficiently on eventual electronic scraps embedded in it. Hence, studies assessing the value embedded in these scraps are rarely available in literature, causing an important gap in both recycling policies and research. The fact that, at present, the management of electronic control units (the most valuable component among automotive electronic equipment) is, as yet, off the radar in both end-of-life vehicles and waste from electric and electronic equipment Directives demonstrates the theory. Of course, their recycling would not contribute in a relevant way to reach the weighted-based recycling and recovery targets characterising current regulations, but would be very important under a critical raw materials recovery view. Results coming from the literature analysis confirm these assumptions.
Subject(s)
Automobiles , Electronic Waste/analysis , Recycling/methods , Waste Management/methodsABSTRACT
BACKGROUND: The nucleolus is a multi-domain enriched with proteins involved in ribosome biogenesis, cell cycle and apoptosis control, viral replication and differentiation of stem cells. Several authors have suggested a role for the nucleolus also in malignant transformation. We have recently demonstrated that under specific circumstances the transcriptional factor EGR1 is shuttled to the nucleolus where it functions as a negative regulator of RNA polymerase I. Since this activity is hampered in ARF -/- cells, and ARF transcription is regulated by EGR1 while the turnover of ARF protein is under the control of B23, we speculated that some sort of cooperation between EGR1 and B23 might also exist. RESULTS: In this work we identified a canonical EGR1 binding site on the B23 promoter through experiments of transactivation and in vitro DNA binding assay. We then found that the levels of B23 expression are directly correlated with those of EGR1, and that this correlation applies to several cellular types and to different stress conditions. Furthermore, we showed that EGR1 stability and accumulation within the nucleolus is in turn regulated by B23 through proteasome involvement, similarly to ARF turnover. CONCLUSION: Our results highlight EGR1 as a regulator of B23 expression actively playing within the newly discovered nucleolar B23-ARF-EGR1 network.
Subject(s)
Early Growth Response Protein 1/metabolism , Neoplasms/metabolism , Nuclear Proteins/genetics , Animals , Base Sequence , Binding Sites , Early Growth Response Protein 1/genetics , Gene Expression Regulation, Neoplastic , Humans , Mice , Mice, Knockout , Molecular Sequence Data , Neoplasms/genetics , Neoplasms/physiopathology , Nuclear Proteins/chemistry , Nuclear Proteins/metabolism , Nucleophosmin , Promoter Regions, Genetic , Protein Binding , Stress, PhysiologicalABSTRACT
Aberrations involving the metasoma in Hymenoptera are well-documented, with one notable teratological case being the fusion of metasomal terga, named symphysomery. This aberration, characterized by the fusion of the second and third terga, has been observed in various species groups of Hedychridium, spanning from Southern Africa to Central Asia. Similar aberrations were noted in Prochridium Linsenmaier from Mongolia and Anachrysis Krombein from Southern Africa. The monotypic genus Oligogaster Soliman & Kimsey is distinguished by two visible metasomal terga. However, the sole specimen of Oligogaster kimseyae Soliman, the type species of the genus, is here considered an aberrant specimen affected by symphysomery, exhibiting the fusion of the second and third metasomal terga. Consequently, Oligogaster Soliman & Kimsey is here synonymized with Hedychridium Abeille de Perrin.
Subject(s)
Hymenoptera , Wasps , Animals , Animal Distribution , Animal Structures , Body SizeABSTRACT
Psoriasis is a chronic inflammatory disease affecting skin and joints characterized by a chronically altered immune and inflammatory response. Several factors occur from the onset to the development of this disease due to different types of cells spatially and temporally localized in the affected area, such as, keratinocytes, macrophages, neutrophils and T helper lymphocytes. This scenario leads to the chronic release of high levels of inflammatory mediators (i.e., IL-17, IL-23, IL-22, TNF-α, S100 proteins, Defensins) and lastly parakeratosis and thickening of the stratum spinosum. Extracellular vesicles (EVs) are small double membraned biological nanoparticles that are secreted by all cell types and classified, based on dimension and biogenesis, into exosomes, microvesicles and apoptotic bodies. Their role as vessels for long range molecular signals renders them key elements in the pathogenesis of psoriasis, as well as innovative platforms for potential biomarker discovery and delivery of fine-tuned anti-inflammatory therapies. In this review, the role of EVs in the pathogenesis of psoriasis and the modulation of cellular microenvironment has been summarized. The biotechnological implementation of EVs for therapy and research for new biomarkers has been also discussed.
Subject(s)
Biomarkers , Extracellular Vesicles , Psoriasis , Humans , Psoriasis/immunology , Psoriasis/metabolism , Psoriasis/etiology , Extracellular Vesicles/metabolism , Extracellular Vesicles/immunology , Animals , Skin/pathology , Skin/immunology , Skin/metabolism , Cellular Microenvironment/immunologyABSTRACT
Oxidative stress represents a hallmark for many degenerative pathologies of the Central Nervous System. Throughout life, the constant pressure of noxious stimuli and/or episodes of traumatic events may expose the brain to a microenvironment where the non-balanced reactive oxygen species inevitably lead to neuronal loss and cognitive decline. HO-1, a 32 kDa heat-shock protein catalyzing the degradation of heme into carbon monoxide (CO), iron and biliverdin/bilirubin is considered one of the main antioxidant defense mechanisms playing pivotal roles in neuroprotection. Restoring the redox homeostasis is the goal of many natural or synthetic antioxidant molecules pursuing beneficial effects on brain functions. Here, we investigated the antioxidant capacity of four selected benzofuran-2-one derivatives in a cellular model of neurodegeneration represented by differentiated SH-SY5Y cells exposed to catechol-induced oxidative stress. Our main results highlight how all the molecules have antioxidant properties, especially compound 9, showing great abilities in reducing intracellular ROS levels and protecting differentiated SH-SY5Y cells from catechol-induced death. This compound above all seems to boost HO-1 mRNA and perinuclear HO-1 protein isoform expression when cells are exposed to the oxidative insult. Our findings open the way to consider benzofuran-2-ones as a novel and promising adjuvant antioxidant strategy for many neurodegenerative disorders.
ABSTRACT
Acetylcholine signaling is attenuated in early Alzheimer's disease (AD) and other dementias. A significant reduction in the expression of nicotinic acetylcholine receptors (nAChRs) in the brain of AD patients has also been reported in several molecular biological and in situ labeling studies. The modulation of the functional deficit of the cholinergic system as a pharmacological target could therefore have a clinical benefit, which is not to be neglected. This systematic review was conducted to identify clinical trials, which evaluated the safety and efficacy of nicotinic acetylcholine receptor agonists using Clinicaltrial (CT) and EudraCT databases. Structured searches identified 39 trials, which used 15 different drugs designed to increase the function of the nAChRs. Most of the identified clinical trials were phase II trials, with some of them classified as ongoing for several years. The systematic screening of the literature led to the selection of 14 studies out of the 8261 bibliographic records retrieved. Six trials reported detailed data on adverse events associated with the intervention, while twelve trials reported data on efficacy measures, such as attention, behavior and cognition. Overall, smost of the physical side effects of cholinergic agonists were reported to be well tolerated. Some trials also reported improvements in attention. However, the efficacy of these drugs in other cognitive and behavioral outcomes remains highly controversial.
Subject(s)
Alzheimer Disease , Receptors, Nicotinic , Humans , Alzheimer Disease/metabolism , Receptors, Nicotinic/metabolism , Brain/metabolism , Nicotinic Agonists/pharmacology , Nicotinic Agonists/therapeutic use , Nicotinic Agonists/metabolism , CognitionABSTRACT
Chrysura baiocchii Rosa sp. nov. is described from Iran. Diagnosis of the new species-group Ch. baiocchii and discussions on Ch. radians group and Ch. genalis subgroup are given.
Subject(s)
Hymenoptera , Animal Distribution , Animals , IranABSTRACT
A first checklist of the Iranian Chrysididae is proposed. The list includes 184 species in 20 genera. Seventy species and genera Spinolia Dahlbom, 1854, Spintharina Semenov, 1892, Trichrysis Lichtenstein, 1876 are newly recorded from Iran. New combination is proposed for Chrysura laconiae (Arens, 2001), comb. nov. (from Chrysis) and Chrysurapyrogaster turca (Linsenmaier, 1997), comb. nov. (from Chrysis). New synonymy is proposed for Chrysura barbatula (Linsenmaier, 1968) = Chrysura barbatica Bohart, 1991, syn. nov. The status of Chrysis transcaspica Mocsáry, 1889 is resurrected. Historical data with the comments of current taxonomic position and the specific validity of some species are given.
Subject(s)
Wasps/classification , Wasps/physiology , Animal Distribution , Animals , Female , Iran , Male , Species SpecificityABSTRACT
Information is provided for 143 objectively invalid or unavailable genus-group names used in Chrysididae; 34 are objectively invalid, of which 18 are junior homonyms (five of these are also currently junior subjective synonyms), 18 are junior objective synonyms (two of these are also junior homonyms) of which seven are unjustified emendations, and two are unnecessary replacement names. The remaining 109 names are unavailable; 96 are incorrect subsequent spellings, most of them were originally lapsus calami or misprints, one is hereby deemed to be an incorrect original spelling, eight are nomina nuda, three were originally published as junior synonyms and never adopted before 1961 as valid names of any taxa, and one is a vernacular name previously considered as valid. Gender, type species, taxonomic history and status are given for each name except for incorrect subsequent spellings and unjustified emendations. Some cases of homonymies with taxa currently classified as non-animal are discussed. For two such junior homonyms, denoting genus-group taxa considered as valid in the present work, new replacement names are proposed: Linsenmaierella Rosa & Pavesi nom. nov. for Chrysidella Linsenmaier, nec Pascher; and Rhipidochrysis Rosa & Pavesi nom. nov. for Pleurochrysis Bohart, nec Pringsheim. New generic synonymies are established: consequent on new type-species designations, Leptoglossa Klug becomes a junior objective synonym of Parnopes Latreille syn. nov., and Pyrochloris Klug becomes a junior objective synonym of Euchroeus Latreille syn. nov.; Pseudodichrysis Trautmann is a junior objective synonym of Dichrysis Lichtenstein syn. nov. and the latter is in turn a junior subjective synonym of Chrysis Linnaeus. Platycelia Dahlbom is selected by the authors, acting as First Revisers, as the correct original spelling, and the simultaneously published Platycoelia is therefore deemed to be an incorrect subsequent spelling. The validation of Philoctetes Abeille de Perrin, not available when originally proposed, is discussed. Morphochrysis Rosa & Pavesi gen. nov. (type species: Chrysis pulchella Spinola) is here described; it includes members of the Chrysis pulchella species group previously included in Gonodontochrysis Semenov-Tian-Shanskij & Nikol'skaya, an unavailable name. The Chrysis zaravshanica species group is merged with the pulchella species group. A new specific synonymy within this group is proposed: Chrysis zaravshanica Tarbinsky syn. nov. of C. personata Semenov-Tian-Shanskij.
Subject(s)
Coleoptera , Ctenophora , Wasps , AnimalsABSTRACT
An illustrated catalogue of the Palaearctic types of species and subspecies described by Walter Linsenmaier in Omalus Panzer, 1801 is given. Linsenmaier described 16 species and subspecies of Omalus; most of the primary types are deposited in the collection at the Natur-Museum in Luzern, Switzerland, with the exception of four holotypes which are deposited at the Natural History Museum in London, UK; Nationalparkzentrum in Zernez, Switzerland; Eidgenössische Technische Hochschule in Zurich, Switzerland; and Museo de Naturaleza y Arqueologia in St. Cruz de Tenerife, Spain. A list of the species described and pictures of 13 primary and secondary types are presented. A synthesis of his classification is given, with comments and comparison to modern classification.
ABSTRACT
BACKGROUND: Low-dose-medicine is based on the administration of low doses of biological regulators to restore the immunologic balance altered in the disease. Cytokines are pivotal regulators of cellular and tissue functions and impaired crosstalk, due to an imbalance between specific cytokines, it is fundamental in acute inflammation and diseases correlated to low-grade chronic inflammation. Osteoarthritis is the most prevalent arthritic disease and a leading cause of disability. In the treatment of muscle-skeletal pathologies, the therapeutic integration of conventional medicine with homotoxicology, or low-dose-medicine appears to be beneficial. OBJECTIVE: This study aims to get more insights into the role of inflammatory cytokines and chemokines during the development of osteoarthritis and to evaluate a possible blocking strategy using anti-inflammatory molecules, we resort to an in vitro experimental model using an established human chondrosarcoma cell line that underwent to a well known pro-inflammatory stimulus as bacterial lipopolysaccharide. METHOD: We tested the production of inflammatory-related cytokines and chemokines, and the efficacy of low-dose (LD) administration of anti-inflammatory compounds, namely IL-10 and anti-IL-1, to block inflammatory cellular pathways. RESULTS: Following an inflammatory insult, chondrocytes upregulated the expression of several pro-inflammatory cyto-/chemokines and this induction could be counteracted by LD IL-10 and anti-IL-1. We reported that these effects could be ascribed to an interfering effect of LD drugs with the NF-κB signaling. CONCLUSION: Our results provided a good indication that LD drugs can be effective in inhibiting the inflammatory response in chondrocytes opening the way to new therapies for the treatment of diseases such as osteoarthritis.